Avalyn Pharma Inc. (AVLN) vs Generate Biomedicines, Inc. (GENB)
- Avalyn Pharma Inc. AVLN 27.88 −6.32%
- Generate Biomedicines, Inc. GENB 9.83 −6.29%
Avalyn Pharma Inc. and Generate Biomedicines, Inc. are both Biotechnology companies. Avalyn Pharma Inc. and Generate Biomedicines, Inc. are of similar size ($1.3B and $1.2B). Avalyn Pharma Inc. has the higher net margin (0.00% vs −1,381.8%) and the lower return on invested capital (−127.6% vs 0.00%). Across the 11 metrics below, Avalyn Pharma Inc. leads on 6 and Generate Biomedicines, Inc. on 5.
Valuation
Profitability
| Metric | AVLN | GENB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | 0.00% | (1,382.04%) | 0.00% |
| Net margin | 0.00% | (1,381.76%) | 0.00% |
| Free cash flow margin | 0.00% | (1,199.36%) | 0.00% |
| Return on equity | 0.00% | 1,091.11% | (50.72%) |
| Return on assets | 0.00% | (56.30%) | (45.56%) |
| Return on invested capital | (127.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack